Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci180802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Yoon Mee Yang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Fatty Liver, Colorectal Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Steatotic liver enhances liver metastasis of colorectal cancer (CRC), but this process is not fully understood. Steatotic liver induced by a high-fat diet increases cancer-associated fibroblast (CAF) infiltration and collagen and hyaluronic acid (HA) production. We investigated the role of HA synthase 2 (HAS2) in the fibrotic tumor microenvironment in steatotic liver using Has2 ΔHSC mice, in which Has2 is deleted from hepatic stellate cells. Has2 ΔHSC mice had reduced steatotic liver–associated metastatic tumor growth of MC38 CRC cells, collagen and HA deposition, and CAF and M2 macrophage infiltration. We found that low–molecular weight HA activates Yes-associated protein (YAP) in cancer cells, which then releases connective tissue growth factor to further activate CAFs for HAS2 expression. Single-cell analyses revealed a link between CAF-derived HAS2 and M2 macrophages and CRC cells through CD44; these cells were associated with exhausted CD8 + T cells via programmed death–ligand 1 and programmed cell death protein 1 (PD-1). HA synthesis inhibitors reduced steatotic liver–associated metastasis of CRC, YAP expression, and CAF and M2 macrophage infiltration, and improved response to anti–PD-1 antibody. In conclusion, steatotic liver modulates a fibrotic tumor microenvironment to enhance metastatic cancer activity through a bidirectional regulation between CAFs and metastatic tumors, enhancing the metastatic potential of CRC in the liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Department of Pharmacy.
- Multidimensional Genomics Research Center, and.
- Innovative Drug Development Research Team for Intractable Diseases (BK21 plus), Kangwon National University, Chuncheon, South Korea.
- Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Samuel Oschin Comprehensive Cancer Institute.
Förderung
- NIAAA NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- NIH National Center for Advancing Translational Science
- Cedars-Sinai Medical Center
- National Research Foundation of Korea
Zitieren
APA
Yang, Y. M., Kim, J., Wang, Z., Kim, J., Kim, S. Y., Cho, G. J., Lee, J. H., Kim, S. M., Tsuchiya, T., Matsuda, M., Pandyarajan, V., Pandol, S. J., Lewis, M. S., Gangi, A., Noble, P. W., Jiang, D., Merchant, A., Posadas, E. M., Bhowmick, N. A., …, & Seki, E. (2025). Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment. Journal of Clinical Investigation. https://doi.org/10.1172/jci180802
Vancouver
Yang YM, Kim J, Wang Z, Kim J, Kim SY, Cho GJ, et al. Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment. Journal of Clinical Investigation. 2025. doi:10.1172/jci180802
BibTeX
@article{Yang2025,
author = {Yang, Yoon Mee and Kim, Jieun and Wang, Zhijun and Kim, Jina and Kim, So Yeon and Cho, Gyu Jeong and Lee, Jee Hyung and Kim, Sun Myoung and Tsuchiya, Takashi and Matsuda, Michitaka and Pandyarajan, Vijay and Pandol, Stephen J and Lewis, Michael S and Gangi, Alexandra and Noble, Paul W and Jiang, Dianhua and Merchant, Akil and Posadas, Edwin M and Bhowmick, Neil A and Lu, Shelly C and You, Sungyong and Xu, Alexander M and Seki, Ekihiro},
title = {Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci180802}
}
EUVIMED